apomorphine has been researched along with cp 293019 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brooks, EW; Mansbach, RS; Sanner, MA; Zorn, SH | 1 |
| Chappie, TA; Collins, JL; Desai, KA; Duignan, DB; Dunaiskis, AR; Faraci, WS; Fliri, AF; Jackson, ER; Johnson, CG; Lee, JS; Majchrzak, MJ; Morrone, JM; Prete Di, CC; Sanner, MA; Seymour, PA; Trozzi, A; Zorn, SH | 1 |
2 other study(ies) available for apomorphine and cp 293019
| Article | Year |
|---|---|
Selective dopamine D4 receptor antagonists reverse apomorphine-induced blockade of prepulse inhibition.
Topics: Animals; Apomorphine; Cell Line; Dopamine Antagonists; Humans; Male; Piperazines; Pyrazines; Pyridines; Pyrimidines; Pyrroles; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D4; Reflex, Startle; Sulfonamides | 1998 |
Synthesis, SAR and pharmacology of CP-293,019: a potent, selective dopamine D4 receptor antagonist.
Topics: Animals; Apomorphine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Design; Haloperidol; Indicators and Reagents; Molecular Structure; Motor Activity; Pyrazines; Pyrimidines; Rats; Receptors, Dopamine D4; Structure-Activity Relationship | 1998 |